Cite
HARVARD Citation
Watz, H. et al. (2019). Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial. Pulmonary pharmacology & therapeutics. pp. 86-93. [Online].